Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6528
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases ; volume:10 ; number:2 ; day:17 ; month:4 ; year:2021 ; pages:337-348 ; date:6.2021
Ophthalmology and therapy ; 10, Heft 2 (17.4.2021), 337-348, 6.2021
- Urheber
-
Chakraborty, Debdulal
Stewart, Michael W.
Sheth, Jay U.
Sinha, Tushar K.
Boral, Subhendu
Das, Arnab
Mondal, Soumen
Mukherjee, Angshuman
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40123-021-00345-2
- URN
-
urn:nbn:de:101:1-2021061420293836479578
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
09.08.20252025, 09:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chakraborty, Debdulal
- Stewart, Michael W.
- Sheth, Jay U.
- Sinha, Tushar K.
- Boral, Subhendu
- Das, Arnab
- Mondal, Soumen
- Mukherjee, Angshuman
- SpringerLink (Online service)
Ähnliche Objekte (12)
Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration
Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series
Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration
Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series
Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration
Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study